// App-Quantinova.ai

OP056 : The first establishment of early healing profile and 9-month outcomes of a new polymer-free Biolimus-A9 drug-coated-stent by longitudinal sequential OCT follow-ups: the EGO-BioFreedom study

Researchers

Presenter

  • Lee W.L.S

Principal Investigators

  • Chan K.W.K

  • Lam C.C.S

  • Mintz G

  • Maehara A

  • Kong S.L

  • Tam C.C.F

  • Wong K.L.M

  • Wong Y.T.A

  • Yung S.Y.A

  • Shea P.G.C

  • Zhang L.W

  • Lam Y.M

Medical Centers

  • Queen Mary Hospital, University of Hong Kong, Hong Kong, Hong Kong

Locations

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Restenosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Biolimus A9

  • Umirolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved